ReoPro (abciximab) to inhibit blood clotting

You'll hear more about using ReoPro (abciximab) to inhibit blood clotting.

This biotech drug came out earlier this year in the U.S. Lilly expects to market it soon in Canada as well.

ReoPro is for patients undergoing balloon help keep the coronary artery open.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote